You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
27 April 2026 - Swedish biotechnology company Cantargia AB (STO:CANTA) on Monday reported early results from an ongoing Phase 1b/2a trial evaluating nadunolimab in combination therapies for high-risk myelodysplastic syndrome (MDS) and acute myelogeno...
27 April 2026 - Medical technology group AOTI INC (AIM: AOTI) on Monday announced results from a large real-world multicentre study demonstrating high rates of durable healing in chronic lower extremity wounds using its Topical Wound Oxygen (TWO2) th...
27 April 2026 - WuXi Biologics (HK:2269), a China-based, global Contract Research, Development and Manufacturing Organisation (CRDMO), announced on Friday the structural completion and key equipment arrival at its microbial commercial manufacturing s...
27 April 2026 - HanchorBio Inc (TPEx:7827), a Taiwan-based global clinical-stage biotechnology company advancing next-generation immunotherapies for immuno-oncology and immune-related diseases, announced on Friday that it has selected Bloomberg to su...
27 April 2026 - Chinese pharmaceutical company Ascletis Pharma Inc (HKEX:1672) on Sunday announced completion of enrolment in its 13-week US Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist, for the treatment of...
24 April 2026 - French pharmaceutical company Servier announced on Thursday the successful completion of its tender offer to acquire all of the issued and outstanding shares of common stock of Day One Biopharmaceuticals Inc (Nasdaq:DAWN), a US biopha...
24 April 2026 - Indian pharmaceutical company Cipla Limited (BSE:500087) (NSE:CIPLA-EQ) and its US subsidiary Cipla USA Inc announced on Thursday that the US Food and Drug Administration (FDA) has given final approval for the Abbreviated New Drug App...